c Fifty-seven carbapenem-resistant Klebsiella pneumoniae isolates belonging to ST11 (50 isolates), ST423 (5 isolates), and two other sequence types were studied. All were positive for bla KPC-2 , bla TEM-1 , and bla CTX-M-14 . SDS-PAGE analysis of six representative isolates demonstrated varied porin expression. Nevertheless, when bla KPC-2 was deleted, carbapenem resistance was markedly reduced. Additionally, SHV-12, DHA-1, and/or VIM-1 appeared to contribute to accessory carbapenemase activity. In contrast, OmpK35 and/or OmpK36 deficiency seemed to serve only as a minor cooperative factor. Table S1 in the supplemental material for primer details). Standard multilocus sequence typing (MLST) protocols were utilized, with alternative primers for gapA, mdh, rpoB, and tonB used as required. Fifty isolates belonged to ST11, five belonged to ST423, and one each belonged to ST65 and a novel MLST type, ST977. The first carbapenem-resistant isolate, derived from a urine specimen obtained in August 2006, belonged to ST423. However, only four other ST423 isolates were detected over the study period. In contrast, ST11 remained endemic throughout this period. Intriguingly, isolates belonging to ST65 and ST977 appeared only once. Except for XJ-2 and XJ-4, which exhibited lower carbapenem MICs, all 57 isolates showed high-level resistance to ampicillin, cefotaxime, ceftazidime, imipenem, meropenem, and ertapenem. PCR analysis suggested that all but two isolates produced TEM-1, KPC-2, CTX-M-14, and SHV-12; bla was not detected in XJ-1 and XJ-4. In addition, all five ST423 isolates encoded DHA-1, and the XJ-5 (ST11) isolate uniquely produced VIM-1.
C
arbapenem MICs of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae vary widely from isolate to isolate, supporting the involvement of other factors (1) (2) (3) (4) . Indeed, Landman et al. (5) have demonstrated that carbapenem MICs are negatively correlated with OmpK36 expression, and Doménech-Sánchez et al. (6) have shown that loss of OmpK35 is associated with increased resistance to cephalosporins and carbapenems. However, other studies have shown that reduced expression of OmpK35 or OmpK36 alone does not significantly alter carbapenem MICs (7) (8) (9) .
We analyzed 57 KPC-producing K. pneumoniae isolates collected from 2006 to 2009 at Huashan Hospital, Shanghai, China, using disc-based and/or Etest susceptibility testing. Colony PCR assays for bla IMP , bla VIM , bla KPC , bla CTX-M , bla SHV , and bla TEM and six plasmid-borne genes (bla ACC , bla CIT , bla DHA , bla ENT/EBC , bla FOX , and bla MOX ) that code for AmpC enzymes were performed (see Table S1 in the supplemental material for primer details). Standard multilocus sequence typing (MLST) protocols were utilized, with alternative primers for gapA, mdh, rpoB, and tonB used as required. Fifty isolates belonged to ST11, five belonged to ST423, and one each belonged to ST65 and a novel MLST type, ST977. The first carbapenem-resistant isolate, derived from a urine specimen obtained in August 2006, belonged to ST423. However, only four other ST423 isolates were detected over the study period. In contrast, ST11 remained endemic throughout this period. Intriguingly, isolates belonging to ST65 and ST977 appeared only once. Except for XJ-2 and XJ-4, which exhibited lower carbapenem MICs, all 57 isolates showed high-level resistance to ampicillin, cefotaxime, ceftazidime, imipenem, meropenem, and ertapenem. PCR analysis suggested that all but two isolates produced TEM-1, KPC-2, CTX-M-14, and SHV-12; bla was not detected in XJ-1 and XJ-4. In addition, all five ST423 isolates encoded DHA-1, and the XJ-5 (ST11) isolate uniquely produced VIM-1.
Isolates XJ-1, XJ-2, and XJ-3, representative of ST977, ST65, and ST423, respectively, were chosen for further analysis together with three ST11 isolates: XJ-4 because it had relatively low carbapenem MICs, XJ-5 because it had a supplementary bla VIM-1 gene, and XJ-6 because it was typical of most ST11 isolates. SDS-PAGE analysis of outer membrane proteins extracted as described previously (10) from cells grown overnight with shaking at 37°C in nutrient broth with or without 10 g/liter NaCl showed that XJ-1 expressed smaller quantities of OmpK36, while OmpK35 production was not detected for XJ-1, XJ-4, and XJ-5 ( Fig. 1) . Furthermore, as the likely OmpK36 protein bands of XJ-3 and XJ-6 were shifted upwards (see below for details), the status of OmpK35 bands in these strains could not be determined (Fig. 1) .
Although DNA mutations relative to that of NTUH-K2044 were detected in the ompK35 sequences of XJ-4, XJ-5, and XJ-6, no amino acid changes were predicted (Fig. 2) . In contrast, the predicted OmpK35 of XJ-1 exhibited 25 amino acid substitutions and a single insertion, while the corresponding sequence of XJ-2 varied by a single amino acid substitution only. The OmpK35 protein of XJ-3 lacked a five-amino-acid string (EIYNK), which mapped to the B1 ␤-sheet. This string of amino acids was strictly conserved in the OmpK35 sequences of the remaining five clinical isolates, NTUH-K2044, and MGH 78578, the last being the most divergent example analyzed (Fig. 2) . The ompK36 sequences in XJ-3 and XJ-6 showed five sets of identical in-frame insertions and deletions that were predicted to lead to 9 additional amino acid residues and an increase in mass of approximately 1 kDa. Interestingly, this variant possessed an inserted aspartic acid-glycine pair that lay directly adjacent to the highly conserved L3 loop-borne PEFXG motif. Indeed, an identically placed aspartic acid-threonine insertion has previously been proposed to lead to OmpK36 functional deficiency (Fig. 2) (11, 12) . Extending this theme, we hypothesize that other amino acid sequence changes identified in OmpK35 and OmpK36, particularly those mapping to predicted secondary structural features, may also impact carbapenem resistance. Finally, we failed to amplify the entire ompK36 XJ-1 coding sequence despite using multiple primer pairs, suggesting that it was affected by a deletion and/or rearrangement.
We next deleted bla KPC-2 to examine its contribution to car- bapenem resistance. Allelic replacement with a fragment tagged with the hygromycin resistance gene from pMQ300 (13) (see Fig.  S1 in the supplemental material) was facilitated by -Red recombination as described previously (14) . The XJ-2-derived mutant remained positive for bla KPC-2 despite PCR confirmation of the intended allelic exchange, suggesting the presence of a second bla KPC-2 copy. For XJ-1 and XJ-4, which lacked SHV-12, DHA-1, and VIM-1, deletion of bla KPC-2 resulted in a Ͼ8-fold decrease in carbapenem MICs, regardless of OmpK35 and OmpK36 expression levels (Fig. 1) . Most remarkably, XJ-1, which exhibited MICs in excess of 32 mg/liter for all three carbapenems, no detectable OmpK35, and deficient expression of OmpK36, became sensitive to all three agents following deletion of bla KPC-2 (Table 1) , suggesting that dual porin deficiency is only a cooperative factor and insufficient on its own to confer carbapenem resistance. In contrast, when bla KPC-2 was deleted from the SHV-12-encoding XJ-6, the resultant mutant exhibited reduced but relatively high imipenem (0.5 mg/liter), meropenem (0.25 mg/liter), and ertapenem (6 mg/liter) MICs. Similarly, the SHV-12-and DHA-1-encoding ⌬XJ-3 exhibited reduced but still clinically significant meropenem (1 mg/liter), imipenem (4 mg/liter), and ertapenem (Ն32 mg/ liter) MICs (Table 1) . Likewise, carbapenem MICs of the bla SHV-12 -and bla VIM-1 -encoding ⌬XJ-5 were much greater than those of ⌬XJ-4 (Table 1) , despite both exhibiting no OmpK35 band and broadly equivalent OmpK36 expression levels, suggesting that VIM-1 (15) and/or SHV-12 was contributing to carbapenem resistance in XJ-5.
In conclusion, we found that bla KPC-2 was the key factor contributing to carbapenem resistance in the isolates studied and that deficient expression of OmpK35 and/or OmpK36 serves only as a cooperative factor. Additionally, our data support the idea that expression of two or more carbapenem-inactivating enzymes, even in the absence of porin deficiencies, leads to markedly elevated carbapenem MIC levels. Collectively, these findings add to the growing appreciation of the multiple pathways exploited by K. pneumoniae to evade carbapenems (4-6, 12, 15, 16) .
Nucleotide sequence accession numbers. Coding sequences of ompK35 and ompK36 were amplified, sequenced, and submitted to GenBank under the following accession numbers: JX310550, JX310551, JX310552, JX310553, JX310554, JX310555, JX310556, JX310557, JX276743, JX291113, and JX291114.
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